Forskolin (Coleus forskohlii).

Forskolin activates adenylate cyclase, the enzyme that makes cyclic AMP, while caffeine inhibits the phosphodiesterases that break cyclic AMP down. Raising production and slowing clearance at the same time holds cyclic AMP signalling higher than either compound does alone.

Cyclic AMP raised by forskolin activates protein kinase A and hormone-sensitive lipase, which releases fatty acids from stored triglyceride. Carnitine carries free fatty acids across the mitochondrial membrane through carnitine palmitoyltransferase, so the second step handles what the first one liberates.

Forskolin is a poorly soluble diterpene with limited oral uptake. Piperine slows intestinal and hepatic phase II conjugation, a main route that clears lipophilic plant compounds on first pass, though the effect has been measured on other compounds rather than on forskolin itself.

Forskolin activates adenylate cyclase to make cyclic AMP, while methylxanthines block the phosphodiesterase that breaks it down. Raising synthesis and slowing degradation act on the same second messenger from both directions.

Green tea supplies both caffeine and catechins that slow phosphodiesterase and catechol-O-methyltransferase activity. The cyclic AMP forskolin generates therefore persists longer in the cell.

Capsaicin acting on TRPV1 promotes catecholamine release, and those catecholamines signal through beta receptors onto adenylate cyclase. Forskolin activates that same enzyme directly, so the two arrive at cyclic AMP by different routes.

Cyclic AMP relaxes vascular smooth muscle, and arginine feeds nitric oxide synthase which relaxes it through cyclic GMP. Two relaxation signals at once can move normal blood pressure further than intended, which matters for anyone already taking blood pressure medicine.

Citrulline raises plasma arginine and therefore nitric oxide production, adding a cyclic GMP relaxation signal to the cyclic AMP one forskolin creates. The vasodilatory effects stack.

Dietary nitrate is reduced to nitrite and then nitric oxide, relaxing smooth muscle through cyclic GMP. Combined with the cyclic AMP rise from forskolin the vasodilation is additive.

Raising cyclic AMP inside platelets is one of the main brakes on their aggregation, and omega-3 fatty acids shift the thromboxane balance the same way. The two effects add and are worth flagging around surgery.

Garlic organosulfur compounds reduce platelet aggregation while forskolin raises the platelet cyclic AMP that suppresses it. Their effects on normal clotting run in the same direction.

A 2024 review examined EGCG and forskolin together in oral preparations, discussing eye pressure regulation and retinal cell measures. Forskolin raises intracellular cAMP directly while EGCG acts through unrelated polyphenol chemistry, so the two arrive at overlapping readouts by different routes. The review summarises laboratory and clinical reports rather than reporting a new trial of the pair.

Adenylyl cyclase converts ATP to cyclic AMP and its true substrate is the magnesium ATP complex, with a second magnesium ion in the catalytic site. Forskolin activates that enzyme directly, so its whole action depends on adequate magnesium at the catalytic centre. This is textbook enzymology rather than a supplementation finding, and it does not imply that extra magnesium increases the response.

Forskolin increases cAMP production while flavonoids including quercetin inhibit the phosphodiesterases that break cAMP down. The two act on opposite ends of the same second messenger pool, which is the same logic that puts forskolin next to caffeine. The interaction is well described in cell work; its size at supplement intakes in people is not established.

Berberine raises AMP activated protein kinase activity, while forskolin raises cAMP and protein kinase A. The two arms converge on lipid and glucose handling in metabolic tissue and are frequently combined for that reason. No combination trial in people grounds this, so it is a mechanistic pairing.

Chromium is included in weight management formulas for its role in normal macronutrient metabolism, and forskolin is included for its cAMP driven effect on stored triglyceride. The two mechanisms are independent. This is a formulation observation and not a tested combination.

Forskolin is a labdane diterpene with poor aqueous solubility, so it dissolves far better in a lipid than in water. Filling it into a triglyceride carrier keeps it in solution and lets it partition with dietary fat into micelles. The reasoning is physicochemical and does not by itself quantify how much more reaches circulation.

Phospholipid complexes pair a lipophilic plant molecule with phosphatidylcholine so the pair disperses in the gut instead of aggregating. The approach is standard for diterpenes and other poorly soluble botanicals. It is a delivery mechanism; the resulting exposure difference has to be measured per formulation.

Tyrosine is the precursor for dopamine, noradrenaline and adrenaline, and catecholamines raise cAMP through beta adrenergic receptors. Forskolin raises the same second messenger without needing the receptor. The convergence is real biochemistry, but nothing measured supports combining them for an added effect.

Rhodiola rosalins and salidroside act on stress response signalling, and forskolin acts on cyclic AMP, so a combined product stacks two unrelated mechanisms. Blends of the two are widespread in energy and body composition formulas. No combination data exists and this is listed as formulation practice.

Protein kinase A activity downstream of cAMP touches mitochondrial biogenesis signalling, and coenzyme Q10 sits in the respiratory chain itself. Products aimed at cellular energy often carry both. The rationale is mechanistic adjacency rather than a measured interaction.